BECN1 and cancer: Phosphorylation of Beclin1 at S90/93/96 by AMPK increases binding to SLC7A11, while AMPK inhibition and mutation of S90/93/96 compromised the pro-ferroptotic function of Beclin1 in human cancer cell lines [228].